MarketBusiness Wire
Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026
May 21st, 2026 • 3 min read • View Source
Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026
Commercial risk teams are responding with tighter controls, scenario modeling, and broader collaboration across underwriting, claims, and cyber operations.
Leaders continue to prioritize resilience planning while balancing cost, coverage terms, and operational exposure in a changing market cycle.